The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Estrogen Deficiency Induces the Differentiation of IL-17 Secreting Th17 Cells: A New Candidate in the Pathogenesis of Osteoporosis
Open accessAbstract
Th17 cells produce IL-17, and the latter promotes bone loss in collagen-induced arthritis in mice. Blocking IL-17 action in mouse model of rheumatoid arthritis reduces disease symptoms. These observations suggest that Th17 cells may be involved in the pathogenesis of bone loss. However, the role of Th17 cell in estrogen (E2) deficiency-induced bone loss is still not very clear. We investigated the effect of E2 on Th17 differentiation in vivo and IL-17 mediated regulation of osteoclast and osteoblast differentiation. Additionally, effect of IL-17 functional block under E2 deficiency-induced bone loss was studied. In murine bone marrow cells, E2 suppressed IL-17 mediated osteoclast differentiation. IL-17 inhibited formation of mineralized nodules in osteoblasts and this effect was suppressed by E2. E2 treatment to mouse calvarial osteoblasts inhibited the IL-17-induced production of osteoclastogenic cytokines and NF-kB translocation. In ovariectomized mice, there was increase in the number of Th17 cells, transcription factors promoting Th17 cell differentiation and circulating IL-17 levels. These effects were reversed by E2 supplementation. Treatment of neutralizing IL-17 monoclonal antibody to Ovx mice mitigated the E2 deficiency-induced trabecular bone loss and reversed the decreased osteoprotegerin-to-receptor activator of nuclear factor kappa B ligand (RANKL) transcript levels in long bones, increased osteoclast differentiation from the bone marrow precursor cells and decreased osteoblast differentiation from the bone marrow stromal cells. Our findings indicate that E2 deficiency leads to increased differentiation of Th17 cells with attendant up regulation of STAT3, ROR-γt and ROR-α and downregulation of Foxp3 which antagonizes Th17 cell differentiation. Increased IL-17 production in turn induces bone loss by increasing pro-osteoclastogenic cytokines including TNF-α, IL-6 and RANKL from osteoblasts and functional block of IL-17 prevents bone loss. IL-17 thus plays a critical causal role in Ovx-induced bone loss and may be considered a potential therapeutic target in pathogenesis of post menopausal osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Normal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856 · cited 1×
“T cells are key inducers of bone wasting under estrogen deficiency because ovariectomy (Ovx) increases the production of tumor necrosis factor-alpha (TNF-a) by T cells to a level sufficient to augment osteoclastogenesis via the increase in receptor activator of nuclear kappa B ligand (RANKL) [7,8,9,10,11,12,13,14].”
BackgroundKotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
Gregory, C. A., Grady Gunn, W., Peister, A., & Prockop, D. J. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.02.002 · Cited by 1,561
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Interleukin-17 and Type 17 Helper T Cells
Miossec, P., Korn, T., & Kuchroo, V. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0707449 · Cited by 1,409
TH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064 · cited 1×
“In addition, the transcription factor forkhead box P3 (Foxp3), which is induced by transforming growth factor-b (TGF-b) signaling, antagonizes the Th17-cell developmental programme [56].”
BackgroundArron, J. R., & Choi, Y. (2000) · Nature · doi:10.1038/35046196 · Cited by 827
Lubberts, E., Koenders, M. I., Oppers‐Walgreen, B., van den Bersselaar, L., Coenen‐de Roo, C. J. J., Joosten, L. A. B., & van den Berg, W. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20001 · Cited by 709
Molecular Basis and Clinical Application of Biological Markers of Bone Turnover*
CALVO, M. S., EYRE, D. R., & GUNDBERG, C. M. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-333 · Cited by 518
Roggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G., & Pacifici, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251534698 · Cited by 513
Kotake, S., Udagawa, N., Hakoda, M., Mogi, M., Yano, K., Tsuda, E., Takahashi, K., Furuya, T., Ishiyama, S., Kim, K., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1003::aid-anr179>3.0.co;2-# · Cited by 420
Osteoporosis, inflammation and ageing
Ginaldi, L., Di Benedetto, M. C., & De Martinis, M. (2005) · Immunity & Ageing · doi:10.1186/1742-4933-2-14 · Cited by 412 · cited 1×
“A relationship between the immune system and bone has long been speculated as bone loss is an invariable pathology of autoimmune and inflammatory conditions [1,2,3].”
BackgroundThe role of the immune system in the pathophysiology of osteoporosis
Clowes, J. A., Riggs, B. L., & Khosla, S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00334.x · Cited by 359
Baker, P. J., Dixon, M., Evans, R. T., Dufour, L., Johnson, E., & Roopenian, D. C. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.2804-2809.1999 · Cited by 325
Cenci, S., Toraldo, G., Weitzmann, M. N., Roggia, C., Gao, Y., Qian, W. P., Sierra, O., & Pacifici, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533207100 · Cited by 309
Huang, H., Kim, H. J., Chang, E.-J., Lee, Z. H., Hwang, S. J., Kim, H.-M., Lee, Y., & Kim, H.-H. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.74 · Cited by 272
Interleukin-17: a mediator of inflammatory responses
Witowski, J., Książek, K., & Jörres, A. (2004) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-003-3228-z · Cited by 245
Type 17 T helper cells-origins, features and possible roles in rheumatic disease.
Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., & Romagnani, S. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.80 · Cited by 212
Lélu, K., Laffont, S., Delpy, L., Paulet, P.-E., Périnat, T., Tschanz, S. A., Pelletier, L., Engelhardt, B., & Guéry, J.-C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101578 · Cited by 210
Luo, C., Wang, L., Sun, C., & Li, D. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.54 · Cited by 203
Yago, T., Nanke, Y., Ichikawa, N., Kobashigawa, T., Mogi, M., Kamatani, N., & Kotake, S. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22326 · Cited by 197
The role of T lymphocytes in bone metabolism
Weitzmann, M. N., & Pacifici, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00324.x · Cited by 192
Interleukin-17: A novel inflammatory cytokine that bridges innate and adaptive immunity
Yu, J. (2008) · Frontiers in Bioscience · doi:10.2741/2667 · Cited by 178
Weitzmann, M. N., Cenci, S., Rifas, L., Haug, J., Dipersio, J., & Pacifici, R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.328 · Cited by 164
Interleukin‐17: A New Paradigm in Inflammation, Autoimmunity, and Therapy
Kramer, J. M., & Gaffen, S. L. (2007) · Journal of Periodontology · doi:10.1902/jop.2007.060392 · Cited by 161
Modulation of CD28 expression with anti–tumor necrosis factor α therapy in rheumatoid arthritis
Bryl, E., Vallejo, A. N., Matteson, E. L., Witkowski, J. M., Weyand, C. M., & Goronzy, J. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21353 · Cited by 150
Garnero, P., Dargent‐Molina, P., Hans, D., Schott, A., Bréart, G., Meunier, P. J., & Delmas, P. D. (1998) · Osteoporosis International · doi:10.1007/s001980050100 · Cited by 148
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb1754oia8 · Cited by 138
IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner
DeSelm, C. J., Takahata, Y., Warren, J. T., Chappel, J. C., Khan, T., Li, X., Liu, C., Choi, Y., Kim, Y. F., Zou, W., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24165 · Cited by 132
Kitami, S., Tanaka, H., Kawato, T., Tanabe, N., Katono, T., Zhang, F., Suzuki, N., Yonehara, Y., & Maeno, M. (2010) · Biochimie · doi:10.1016/j.biochi.2009.12.011 · Cited by 102
Molecular control of bone remodeling and osteoporosis
Kong, Y., & Penninger, J. M. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00178-9 · Cited by 100
Sarkar, S., Cooney, L. A., White, P., Dunlop, D. B., Endres, J., Jorns, J. M., Wasco, M. J., & Fox, D. A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2838 · Cited by 99
Stamp, L. K., James, M. J., & Cleland, L. G. (2004) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2004.01212.x · Cited by 97
Yu, J. J., Ruddy, M. J., Conti, H. R., Boonanantanasarn, K., & Gaffen, S. L. (2008) · Infection and Immunity · doi:10.1128/iai.01209-07 · Cited by 95
Kamiya, S., Nakamura, C., Fukawa, T., Ono, K., Ohwaki, T., Yoshimoto, T., & Wada, S. (2007) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0766-8 · Cited by 93
Prominent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+ T Cells in TallyHo/JngJ Mice
Won, H. Y., Lee, J.-A., Park, Z. S., Song, J. S., Kim, H. Y., Jang, S.-M., Yoo, S.-E., Rhee, Y., Hwang, E. S., & Bae, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018168 · Cited by 91
A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200939670 · Cited by 87 · cited 1×
“While the studies by Goswami et al, 2009 [26] have shown that Ovx IL-17 receptor knockout mice were more susceptible to bone loss than controls thus suggesting a bone protective role for IL-17 receptor signalling, contrasting observations by our group [27] and DeSelm et al [28] suggested that IL-17…”
ResultTyagi, A. M., Srivastava, K., Sharan, K., Yadav, D. K., Maurya, R., & Singh, D. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021216 · Cited by 76
Self-citationTyagi, A. M., Gautam, A. K., Kumar, A., Srivastava, K., Bhargavan, B., Trivedi, R., Saravanan, S., Yadav, D. K., Singh, N., Pollet, C., et al. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.05.016 · Cited by 75
Self-citationKocić, J., Santibanez, J. F., Krstić, J., Mojsilović, S. B., Djordjević, I. O., Trivanović, D. I., Ilić, V. L., & Bugarski, D. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.001 · Cited by 66
Heparin inhibits osteoclastic differentiation and function
Ariyoshi, W., Takahashi, T., Kanno, T., Ichimiya, H., Shinmyouzu, K., Takano, H., Koseki, T., & Nishihara, T. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21559 · Cited by 55
Tyagi, A. M., Srivastava, K., Kureel, J., Kumar, A., Raghuvanshi, A. S., Yadav, D., Maurya, R., Goel, A., & Singh, D. R. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1650-x · Cited by 54
Self-citationPhysiological Principles of Endocrine Replacement: Estrogen
Burger, H. (2001) · Hormone Research in Paediatrics · doi:10.1159/000048141 · Cited by 50
T cells and post menopausal osteoporosis in murine models.
Pacifici, R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2126 · Cited by 45
Age‐related changes in the occurrence and characteristics of thymic CD4+ CD25+ T cells in mice
Kozłowska, E., Biernacka, M., Ciechomska, M., & Drela, N. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02667.x · Cited by 44
Oostlander, A. E., Everts, V. E., Schoenmaker, T., Bravenboer, N., van Vliet, S. J., Bodegraven, A. A. V., Lips, P. T. A. M., & de Vries, T. J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23352 · Cited by 41
Kosmaczewska, A., Świerkot, J., Ciszak, L., & Wiland, P. (2011) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.948971 · Cited by 36
Tarjanyi, O., Boldizsar, F., Nemeth, P., Mikecz, K., & Glant, T. T. (2009) · Immunity & Ageing · doi:10.1186/1742-4933-6-8 · Cited by 32 · cited 1×
“Adult Balb/c mice (9–10 week-old) were used for the studies [39,40,41,42].”
MethodType 17 T-helper cells might be a promising therapeutic target for osteoporosis
Yuan, F., Li, X., Lü, W., Zhao, Y., Li, C.-W., Li, J.-P., Sun, J., & Xu, R. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0797-z · Cited by 26
Yang, W. C., Ding, X., Deng, J., Lu, Y., Matsuda, Z., Thiel, A., Chen, J., Deng, H., & Qin, Z. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0711-5 · Cited by 24
Holland, J., Brennan, O., Kennedy, O. D., Rackard, S. M., O’Brien, F. J., & Lee, T. C. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01376.x · Cited by 12
Mainini, G., Incoronato, M., Urso, L., & Scaffa, C. (2011) · PubMed · Cited by 8
Cited by
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
Peckham, H., de Gruijter, N. M., Raine, C., Radziszewska, A., Ciurtin, C., Wedderburn, L. R., Rosser, E. C., Webb, K., & Deakin, C. T. (2020) · Nature Communications · doi:10.1038/s41467-020-19741-6 · Cited by 1,503
Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics
Li, J.-Y., Chassaing, B., Tyagi, A. M., Vaccaro, C., Luo, T., Adams, J., Darby, T. M., Weitzmann, M. N., Mulle, J. G., Gewirtz, A. T., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86062 · Cited by 643
Self-citationSex Hormones in Acquired Immunity and Autoimmune Disease
Moulton, V. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02279 · Cited by 620
Osteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
Metadata
- Authors
- Tyagi, A. M., Srivastava, K., Mansoori, M. N., Trivedi, R., Chattopadhyay, N., & Singh, D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-10
- Volume
- 7
- Issue
- 9
- Pages
- e44552
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2135261840
- Cited by
- 326
- References
- 54
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.